CDKN2A loss has also been observed to drive NF1 associated malignant transformation in neurofibromas, which may suggest an interaction between CDKN2A and NF1 in other tumor histologies as well that can potentially affect patient outcome (Fig. 3e, f; Table 4) [22]. The gene discussed is NF1; the disease is plexiform neurofibroma.